QuidelOrtho Corporation QDEL Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total revenues by Business | ||||||
| China | $323.2M-0.2% | $334.7M+3.0% | $329.9M+4.7% | $325.7M+3.1% | $323.9M+2.6% | |
| EMEA | $364.3M+7.2% | $360.7M+7.4% | $353.9M+3.8% | $346.1M+4.5% | $339.9M+2.8% | |
| North America | $1.41B-11.4% | $1.49B-8.1% | $1.5B-10.3% | $1.55B-8.6% | $1.59B-7.8% | |
| Segment Information, Other Income (Expense) by Business | ||||||
| China | $1.3M-45.8% | $1.1M-54.2% | $1M-63.0% | $2.1M+5.0% | $2.4M+167% | |
| EMEA | -$3.2M-28.0% | -$4M-186% | -$4.2M-273% | -$4M-281% | -$2.5M-5.3% | |
| North America | -$500K-183% | -$300K-160% | $0-100% | $100K-71.4% | $600K+443% | |
| Segment Adjusted EBITDA by Business | ||||||
| China | $132.4M-1.0% | $141.2M+8.2% | $140.1M+7.9% | $140.1M+7.5% | $133.7M+7.1% | |
| EMEA | $86.2M+67.7% | $82.6M+77.6% | $69.1M+25.9% | $57.6M+10.3% | $51.4M+13.2% | |
| North America | $742.1M-16.6% | $807M-9.5% | $826.7M-16.3% | $863.9M-13.0% | $889.8M-9.5% | |
| Cost of sales, excluding amortization of intangibles by Business | ||||||
| China | $145.4M+1.2% | $147.6M-0.3% | $143.3M+2.5% | $139.2M-1.5% | $143.7M+2.9% | |
| EMEA | $173.2M-5.0% | $175.9M-2.0% | $180.5M+2.9% | $182.9M+4.0% | $182.4M+3.3% | |
| North America | $498.2M-5.6% | $512.1M-6.4% | $500.3M-13.1% | $516.9M-12.6% | $527.7M-16.4% | |
| Selling, marketing and administrative by Business | ||||||
| China | $43.8M-2.2% | $43.9M-1.6% | $43.9M+0.1% | $44.6M+1.9% | $44.8M+2.0% | |
| EMEA | $99.1M-1.9% | $95.4M-9.8% | $97.3M-8.1% | $98.9M-6.7% | $101M-5.2% | |
| North America | $168.7M-3.1% | $167.9M-6.5% | $169.8M-8.7% | $170.9M-12.5% | $174.1M-14.5% | |
| R&D by Business | ||||||
| China | $2.9M-29.3% | $3.1M-27.9% | $3.6M-14.8% | $3.9M-10.3% | $4.1M-8.4% | |
| EMEA | $2.6M0.0% | $2.8M+7.7% | $2.8M+15.5% | $2.7M+10.2% | $2.6M+5.1% | |
| North America | $1.6M0.0% | $1.6M0.0% | $1.6M0.0% | $1.6M0.0% | $1.6M0.0% | |
| Percentage of risk concentration by Product | ||||||
| Respiratory | 36%-14.0pp | 42%-10.0pp | 42%— | 49%— | 50%— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does QuidelOrtho Corporation break its business down?
- QuidelOrtho Corporation (QDEL) reports total revenues by business across 5 parts — China, EMEA, JPAC, Latin America and North America. Each is extracted from the segment footnotes and tracked over time.
- Where does QuidelOrtho Corporation's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in QuidelOrtho Corporation's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
